Yorvipath® (palopegteriparatide)
for Hypoparathyroidism
Yorvipath (palopegteriparatide) is a long-acting parathyroid hormone replacement used to treat adults with hypoparathyroidism. Yorvipath releases PTH (1-34) throughout the day, helping restore normal hormone levels and maintain calcium and phosphate balance. This helps manage both short-term symptoms and long-term complications of the condition.
